APA

Patnaik A., Tolcher A., Papadopoulos K. P., Beeram M., Rasco D., Werner T. L., Bauman J. W., Scheuber A., Cox D. S., Patel B. R., Zhou Y., Hamid M., Schramek D. & Sharma S. (20170606). Phase 1 study to evaluate the effect of the MEK inhibitor trametinib on cardiac repolarization in patients with solid tumours. : Cancer chemotherapy and pharmacology.

Chicago

Patnaik Amita, Tolcher Anthony, Papadopoulos Kyriakos P, Beeram Murali, Rasco Drew, Werner Theresa L, Bauman John W, Scheuber Anita, Cox Donna S, Patel Bela R, Zhou YanYan, Hamid Mohammed, Schramek Daniel and Sharma Sunil. 20170606. Phase 1 study to evaluate the effect of the MEK inhibitor trametinib on cardiac repolarization in patients with solid tumours. : Cancer chemotherapy and pharmacology.

Harvard

Patnaik A., Tolcher A., Papadopoulos K. P., Beeram M., Rasco D., Werner T. L., Bauman J. W., Scheuber A., Cox D. S., Patel B. R., Zhou Y., Hamid M., Schramek D. and Sharma S. (20170606). Phase 1 study to evaluate the effect of the MEK inhibitor trametinib on cardiac repolarization in patients with solid tumours. : Cancer chemotherapy and pharmacology.

MLA

Patnaik Amita, Tolcher Anthony, Papadopoulos Kyriakos P, Beeram Murali, Rasco Drew, Werner Theresa L, Bauman John W, Scheuber Anita, Cox Donna S, Patel Bela R, Zhou YanYan, Hamid Mohammed, Schramek Daniel and Sharma Sunil. Phase 1 study to evaluate the effect of the MEK inhibitor trametinib on cardiac repolarization in patients with solid tumours. : Cancer chemotherapy and pharmacology. 20170606.